IP Verse

Method For Treating Primary Insomnia

PatentPatent Analysis

EP3103443

NEURIM PHARMACEUTICALS
Application Number
EP16172415A
Filing Date
Aug 12, 2002
Status
Granted And Under Opposition
May 28, 2021
Grant Date
Jun 30, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP1441702B1

Bibliography

The patent EP3103443B1 was granted to Neurim Pharmaceuticals on Jun 30, 2021 following the initial filing on Aug 12, 2002 under the application number EP16172415A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMar 29, 2022WITHDRAWN
NEURAXPHARM ARZNEIMITTELMar 29, 2022WITHDRAWN
TEVA PHARMACEUTICALSMar 29, 2022WITHDRAWN
HAMM & WITTKOPPFeb 9, 2022ADMISSIBLE
ORIFARM GENERICSSep 30, 2021ADMISSIBLE
GENERICS UKJun 30, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents